Anna Esposito

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

N-nonyloxypentyl-L-deoxynojirimycin reduces Stenotrophomonas maltophilia virulence in vitro and in Galleria mellonella infection model.

N-nonyloxypentyl-L-deoxynojirimycin reduces Stenotrophomonas maltophilia virulence in vitro and in Galleria mellonella infection model.

Journal: Frontiers in microbiology

Published: March 20, 2026

l-NBDNJ allosteric chaperone for multiple defective enzymes involved in lysosomal storage disorders (LSDs).

l-NBDNJ allosteric chaperone for multiple defective enzymes involved in lysosomal storage disorders (LSDs).

Journal: Bioorganic chemistry

Published: February 12, 2026

Synthesis and preliminary biological evaluation of novel steroidal compounds as antibacterial agents.

Synthesis and preliminary biological evaluation of novel steroidal compounds as antibacterial agents.

Journal: Steroids

Published: August 01, 2025

Synthesis of a di-O-acylated deoxynojirimycin (DNJ) derivative and evaluation of its antibacterial and antibiofilm activity against Staphylococcus aureus and Stenotrophomonas maltophilia.

Synthesis of a di-O-acylated deoxynojirimycin (DNJ) derivative and evaluation of its antibacterial and antibiofilm activity against Staphylococcus aureus and Stenotrophomonas maltophilia.

Journal: Carbohydrate research

Published: October 24, 2024

Synthesis of Natural and Sugar-Modified Nucleosides Using the Iodine/Triethylsilane System as N-Glycosidation Promoter.

Synthesis of Natural and Sugar-Modified Nucleosides Using the Iodine/Triethylsilane System as N-Glycosidation Promoter.

Journal: International journal of molecular sciences

Published: July 17, 2024

Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent.

Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent.

Journal: ACS pharmacology & translational science

Published: January 26, 2024

PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii.

PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii.

Journal: Pathogens (Basel, Switzerland)

Published: October 06, 2023

N-Substituted l-Iminosugars for the Treatment of Sanfilippo Type B Syndrome.

N-Substituted l-Iminosugars for the Treatment of Sanfilippo Type B Syndrome.

Journal: Journal of medicinal chemistry

Published: January 25, 2023

Digging into protein metalation differences triggered by fluorine containing-dirhodium tetracarboxylate analogues.

Digging into protein metalation differences triggered by fluorine containing-dirhodium tetracarboxylate analogues.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: April 28, 2022

Synthesis and antiviral properties of biomimetic iminosugar-based nucleosides.

Synthesis and antiviral properties of biomimetic iminosugar-based nucleosides.

Journal: European journal of medicinal chemistry

Published: April 27, 2022

Reactivity of a fluorine-containing dirhodium tetracarboxylate compound with proteins.

Reactivity of a fluorine-containing dirhodium tetracarboxylate compound with proteins.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: February 15, 2022

The Glucocorticoid PYED-1 Disrupts Mature Biofilms of Candida spp. and Inhibits Hyphal Development in Candida albicans.

The Glucocorticoid PYED-1 Disrupts Mature Biofilms of Candida spp. and Inhibits Hyphal Development in Candida albicans.

Journal: Antibiotics (Basel, Switzerland)

Published: October 14, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026